...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

I'm not sure San Fran. If ZE doesn't do it sooner I believe they'll be left in the scientific dust! cheers. Toinv

Share
New Message
Please login to post a reply